When.com Web Search

  1. Ads

    related to: breast cancer gene test insurance

Search results

  1. Results From The WOW.Com Content Network
  2. Does Medicare cover genetic testing? - AOL

    www.aol.com/lifestyle/does-medicare-cover...

    Breast and ovarian cancers: Medicare may cover genetic testing to determine if a person has a mutation in the BRCA1 and BRCA2 genes, which can help identify their risk of breast and ovarian cancers.

  3. MammaPrint - Wikipedia

    en.wikipedia.org/wiki/MammaPrint

    MammaPrint is based on the Amsterdam 70-gene breast cancer gene signature and uses formalin-fixed-paraffin-embedded (FFPE) or fresh tissue for microarray analysis. [3] It is a laboratory developed test (LDT) which falls into the class of In Vitro Diagnostic Multivariate Index Assays (IVDMIA).

  4. Breast Cancer Gene: Why Most Women Can't Do What Angelina ...

    www.aol.com/news/2013-05-15-angelina-jolie...

    Under the Affordable Care Act, getting the full genetic test for breast cancer will soon become a lot less expensive, at least under some circumstances. Starting in August, insurance companies ...

  5. 23andMe and breast cancer gene testing: What you should know

    www.aol.com/lifestyle/23andme-breast-cancer-gene...

    23andMe DNA Test - Health + Ancestry Personal Genetic Service ($199, Amazon) What is BRCA? While the BRCA gene, known as the "breast cancer gene," is only found in 1 in 400 people and accounts for ...

  6. Elective genetic and genomic testing - Wikipedia

    en.wikipedia.org/wiki/Elective_genetic_and...

    Elective genetic and genomic testing are DNA tests performed ... for by health insurance companies. ... colon cancer or hereditary breast and ovarian cancer. ...

  7. BRCA mutation - Wikipedia

    en.wikipedia.org/wiki/BRCA_mutation

    BRCA-related breast cancer appears at an earlier age than sporadic breast cancer. [9]: 89–111 It has been asserted that BRCA-related breast cancer is more aggressive than normal breast cancer, however most studies in specific populations suggest little or no difference in survival rates despite seemingly worse prognostic factors.

  1. Ads

    related to: breast cancer gene test insurance